RDTCF (Rapid Dose Therapeutics) Other Operating Expense: $0.37 Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rapid Dose Therapeutics Other Operating Expense?

Rapid Dose Therapeutics RDTCF Other Operating Expense is $0.37 Mil as of Feb. 2026. The stock has 3 warning signs investors should review.

Rapid Dose Therapeutics's Other Operating Expense for the three months ended in Feb. 2026 was $0.09 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 was $0.37 Mil.

Rapid Dose Therapeutics's quarterly Other Operating Expense declined from Aug. 2025 ($0.10 Mil) to Nov. 2025 ($0.09 Mil) and declined from Nov. 2025 ($0.09 Mil) to Feb. 2026 ($0.09 Mil).

Rapid Dose Therapeutics's annual Other Operating Expense declined from Feb. 2024 ($0.46 Mil) to Feb. 2025 ($0.17 Mil) but then increased from Feb. 2025 ($0.17 Mil) to Feb. 2026 ($0.38 Mil).

Rapid Dose Therapeutics Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics Other Operating Expense Chart

Rapid Dose Therapeutics Annual Data
Trend Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.49 0.46 0.17 0.38

Rapid Dose Therapeutics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.10 0.10 0.09 0.09

Rapid Dose Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $0.37 Mil mean?
Rapid Dose Therapeutics (RDTCF) has a Other Operating Expense of $0.37 Mil as of Feb. 2026. Other operating expenses that a company records on its income statement. View historical data on Rapid Dose Therapeutics and its competitors.
Is Rapid Dose Therapeutics' Other Operating Expense too high?
Rapid Dose Therapeutics' current Other Operating Expense is $0.37 Mil.
How does Rapid Dose Therapeutics' Other Operating Expense compare to VRTX and REGN?
Rapid Dose Therapeutics' Other Operating Expense of $0.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current Other Operating Expense is $0.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.25, compared to a current price of $0.06 — trading 76% below its estimated fair value. The current Other Operating Expense is $0.37 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current Other Operating Expense is $0.37 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.